Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis

References

• Hardy J. Molecular genetics of Alzheimer's disease. Acta Neurol Scand Suppl 1996;165:13–7.
   PubMedGoogle Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353–6.
   PubMed Web of Science ®Google Scholar
• Ling Y, Morgan K, Kalsheker N. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int J Biochem Cell Biol 2003;35:1505–35.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Watanabe RM, Valle TT, et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000;67:1174–85.
   PubMedGoogle Scholar
• Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000;290:2302–3.
   PubMed Web of Science ®Google Scholar
• Wang DS, Dickson DW, Malter JS. Beta-Amyloid degradation and Alzheimer's disease. J Biomed Biotechnol 2006;2006(3):58406.
   PubMedGoogle Scholar
• Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162–7.
   PubMed Web of Science ®Google Scholar
• Kurochkin IV, Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994;345:33–7.
   PubMed Web of Science ®Google Scholar
• Edbauer D, Willem M, Lammich S, et al. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 2002;277:13389–93.
   PubMed Web of Science ®Google Scholar
• Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349–56.
   PubMed Web of Science ®Google Scholar
• Daw EW, Payami H, Nemens EJ, et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 2000;66:196–204.
   PubMedGoogle Scholar
• Prince JA, Feuk L, Gu HF, et al. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 2003;22:363–71.
   PubMed Web of Science ®Google Scholar
• Ertekin-Taner N, Allen M, Fadale D, et al. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat 2004;23: 334–42.
   PubMed Web of Science ®Google Scholar
• Blomqvist ME, Silburn PA, Buchanan DD, et al. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 2004;5:115–19.
   PubMed Web of Science ®Google Scholar
• Blomqvist ME, Chalmers K, Andreasen N, et al. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 2005;26:795–802.
   PubMed Web of Science ®Google Scholar
• Abraham R, Myers A, Wavrant-DeVrieze F, et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001;109:646–52.
   PubMedGoogle Scholar
• Bian L, Yang JD, Guo TW, et al. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 2004;63:241–5.
   PubMed Web of Science ®Google Scholar
• Boussaha M, Hannequin D, Verpillat P, et al. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 2002;329:121–3.
   PubMedGoogle Scholar
• Edland SD, Wavrant-De Vriese F, Compton D, et al. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett 2003;345:21–4.
   PubMed Web of Science ®Google Scholar
• Nowotny P, Hinrichs AL, Smemo S, et al. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet 2005;136B:62–8.
   PubMedGoogle Scholar
• Liu F, He Y, Peng X, et al. Association of the 8473T>C cyclooxygenase-2 (COX-2) gene polymorphism with lung cancer risk in Asians. Asian Pac J Cancer Prev 2010;11:1257–62.
   PubMedGoogle Scholar
• DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007;28:105–14.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Huang J, et al. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology 2010;15:643–50.
   PubMed Web of Science ®Google Scholar
• Mueller JC, Riemenschneider M, Schoepfer-Wendels A, et al. Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures. Neurobiol Aging 2007;28:727–34.
   PubMedGoogle Scholar
• Vepsalainen S, Parkinson M, Helisalmi S, et al. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population. J Med Genet 2007;44:606–8.
   PubMed Web of Science ®Google Scholar
• Zuo X, Jia J. Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease. Brain Res 2009;1249:1–8.
   PubMed Web of Science ®Google Scholar
• Bjork BF, Katzov H, Kehoe P, et al. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiol Aging 2007;28:1374–80.
   PubMedGoogle Scholar
• Ozturk A, DeKosky ST, Kamboh MI. Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease. Neurosci Lett 2006;406:265–9.
   PubMedGoogle Scholar
• Marlowe L, Peila R, Benke KS, et al. Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. Neurodegener Dis 2006;3:320–6.
   PubMedGoogle Scholar
• Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17–23.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang B, Wan H, et al. Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease. Neurosci Lett 2013;541:132–7.
   PubMed Web of Science ®Google Scholar